80
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
panobinostat
Specified dose on specified days
carfilzomib
Specified dose on specified days
Woodlands Medical Specialists, Pensacola
Florida Cancer Specialists North, St. Petersburg
Florida Cancer Specialists South, Fort Myers
Tennessee Oncology, Nashville
Tennessee Oncology-Chattanooga, Chattanooga
Oncology Hematology Care, Inc., Cincinnati
Providence Medical Group, Terre Haute
RHHP/Hope Cancer Center, Terre Haute
Research Medical Center, Kansas City
Cancer Centers of Southwest Oklahoma, Lawton
The Center for Cancer and Blood Disorders, Fort Worth
Colorado Blood Cancer Institute, Denver
Hematology-Oncology Associates - Northern NJ, Morristown
Collaborators (2)
Onyx Therapeutics, Inc.
INDUSTRY
Novartis
INDUSTRY
SCRI Development Innovations, LLC
OTHER